Credit Suisse »

Bridgebio Pharma shares owned by Credit Suisse

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Credit Suisse

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.7M 91k 40.37
2023-09-30 $19M 723k 26.37
2023-06-30 $13M 769k 17.20
2023-03-31 $12M 733k 16.58
2022-12-31 $3.9M 518k 7.62
2022-09-30 $6.1M 609k 9.95
2022-06-30 $5.2M 573k 9.11
2022-03-31 $6.2M 616k 10.13
2021-12-31 $11M 670k 16.66
2021-09-30 $22M 467k 46.89
2021-06-30 $24M 392k 60.96
2021-03-31 $23M 367k 61.59
2020-12-31 $24M 339k 71.14
2020-09-30 $17M 462k 37.52
2020-06-30 $18M 547k 32.61
2020-03-31 $292k 10k 28.99
2019-12-31 $780k 22k 35.07
2019-06-30 $701k 26k 26.96